High prevalence of cardiovascular risk factors in patients with moderate or severe psoriasis in northern China

By Ma Liangjuan   Li Me   Wang Hefei   Li Yuzhen   Bai Bingxue  

Archives of Dermatological Research, Vol. 306, Iss. 3, 2014-04 ,pp. : 247-251

Springer Publishing Company

Access to resources Recommend Favorite

Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice

By Berends Maartje A. M.   Driessen Rieke J. B.   Langewouters Annechien M. G.   Boezeman Jan B.   van de Kerkhof Peter C. M.   de Jong Elke M. G. J.  

Journal of Dermatological Treatment, Vol. 18, Iss. 2, 2007-01 ,pp. : 76-83

Informa Healthcare

Access to resources Recommend Favorite

Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan

By Igarashi Atsuyuki   Kuwabara Hiroyo   Fahrbach Kyle   Schenkel Brad  

Journal of Dermatological Treatment, Vol. 24, Iss. 5, 2013-10 ,pp. : 351-355

Informa Healthcare

Access to resources Recommend Favorite

Effect of Weight Loss on the Cardiovascular Risk Profile of Obese Patients with Psoriasis

By  

Acta Dermato-Venereologica, Vol. 94, Iss. 6, 2014-11 ,pp. : 691-694

Medical Journals Limited

Access to resources Recommend Favorite

Tolerability and Safety of Biological Therapies for Psoriasis in Daily Clinical Practice: A Study of 103 Italian Patients

By Brunasso Alexandra Maria Giovanna   Puntoni Matteo   Salvini Camilla   Delfino Chiara   Curcic Pero   Gulia Andrea   Massone Cesare  

Acta Dermato-Venereologica, Vol. 91, Iss. 1, 2011-01 ,pp. : 44-49

Medical Journals Limited

Access to resources Recommend Favorite